Pharma and Healthcare Insight provides subscribers with analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting on global pharma and healthcare markets. The service includes online access to the very latest analysis and data, a searchable archive, and PDF access to the monthly regional Insight reports.
Published by Business Monitor International, the global market specialists, Pharma and Healthcare Insight is broken down into five regional services: Asia, Western Europe, Emerging Europe, the Middle East & Africa and the Americas.
To Subscribe and gain full access to content for 12 months, click subscribe now.ยป To access our 
RSS feed of headlines copy this link to your RSS reader
Companies / Brazil
European pharmaceutical wholesale giant Celesio announced on June 29 2009 it had acquired a majority (54%) stake in leading Brazilian drug distributor Panpharma. BMI welcomes the move, noting that an expansion beyond the firm's traditional European borders into a high growth emerging market should provide the company with strong growth potential, while also seemingly stealing...
2009-07-02Industry / Canada
Deaths resulting from heart disease in Canada have fallen by just under a third between 1994 and 2004. Research published in the Canadian Medical Association Journal (CMAJ) also revealed...
2009-07-01Industry / United States
A study carried out by global logistics firm UPS has revealed that regulatory issues top the list of supply chain concerns expressed by pharmaceutical companies. Among large pharmaceutical...
2009-06-30Industry / Vietnam
Vietnam has introduced its first domestically-produced measles vaccine. This means the South East Asian country's 10-vaccine National Expanded Immunisation Programme (NEIP) is now self-sufficient. BMI believes that other developing countries should follow Vietnam's example, rather than relying on multinational drugmakers or non-government organisations, both of which have agendas...
2009-07-02Industry / India
The highly promising biosimilar sector has two new players. US-based Mylan has entered into a partnership with Indian firm Biocon to develop copies of medicines produced using biotechnology....
2009-07-01Industry / United Kingdom
Despite the local pricing regulator recently turning down the expanded use of its key drug, Japanese pharmaceutical company
2009-06-30Industry
The European Medicine Association (EMEA)'s Committee for Medicinal Products for Human Use (CHMP) June plenary meeting has resulted in the approval of six new medicinal products, bringing the total number of new products approved in the first five monthly meetings of 2009 to 23. Here BMI examines the details of the positive opinions for new drugs, while providing an overview of...
2009-07-02Industry / Romania
Over 20 pharmaceutical distributors in Romania have suspended supplies to almost half of the country's hospitals and pharmacies, as a result of the accumulation of debts of over RON1bn...
2009-07-01Companies / Hungary
Hungary-based Gedeon Richter has acquired licensing rights to a number of technology platforms and women's health products from US speciality firm KV Pharmaceutical. Richter will...
2009-06-26Industry / South Africa
Indian drugmaker Aurobindo's latest foray into South Africa has lead to an unexpected change in tone by the country's government. The state procurement authorities have preferentially rejected Aurobindo's tendered price for antiretrovirals (ARVs), despite being around 40% cheaper than those offered by domestic pharmaceutical firms. Aurobindo is now suing the South African Treasury,...
2009-07-01Industry / Tanzania
Tanzania's Medical Stores Department (MSD) has fallen under scrutiny for failing to regulate the supply and distribution of medicines in the country. In 2008, over 4,000 health providers...
2009-06-29Industry / Israel
In a positive development for Israeli drugmakers, the EU will recognise that Good Manufacturing Practices adopted within the country are sufficient not to warrant additional testing...
2009-06-29Industry / Spain
With the aim of ensuring the steady future availability of a supply of vaccines against seasonal and pandemic flu, the Spanish government has signed a deal with US-based Novavax to license its vaccine production technology and construct the country's first vaccine manufacturing plant.
2009-07-02Industry / United Kingdom
Swiss drugmaker Roche has announced its decision not to renew its membership of the Association of British Pharmaceutical Industry (ABPI) and is also understood to be leaving PhRMA,...
2009-07-02Industry
In another wave of acquisition activity in the pharmaceutical industry, Sanofi-Aventis has announced that it will be considering further purchases of smaller generic drugmakers. Unlike...
2009-06-30
